Table 2 Providers' awareness of and knowledge about xylazine and treating xylazine- related complications (n = 78)
Characteristics | Frequency | % |
|---|---|---|
Xylazine awareness (n = 72) | ||
Has heard of xylazine | 69 | 95.8 |
Xylazine knowledge (n = 72) | ||
Knows xylazine is not a novel central-acting opioid (n = 71) | 51 | 71.8 |
Knows xylazine exposure may lead to wounds | 68 | 94.4 |
Knows xylazine is not FDA-approved for use in humans | 72 | 100.0 |
Knows naloxone cannot reverse a xylazine overdose | 69 | 95.8 |
Knows xylazine is almost exclusively found with fentanyl | 55 | 76.5 |
Knows xylazine is added to fentanyl to prolong the high | 67 | 93.1 |
Number of patients seen with known/expected xylazine exposure (n = 77) | ||
0 | 13 | 16.9 |
1–5 | 25 | 32.5 |
6–10 | 10 | 13.0 |
11 + | 11 | 14.3 |
I don't know | 18 | 23.4 |
Frequency patients have discussed xylazine with provider | ||
Often | 8 | 10.3 |
Sometimes | 20 | 25.6 |
Rarely | 23 | 29.6 |
Never | 27 | 34.6 |
Confidence recognizing xylazine complications in patients (n = 71) | ||
Extremely confident | 5 | 7.0 |
Confident | 18 | 25.4 |
Some confidence | 27 | 38.0 |
Little confidence | 15 | 21.1 |
Not at all confident | 6 | 8.5 |
Confidence Treating Xylazine Complications in Patients (n = 71) | ||
Extremely confident | 4 | 5.6 |
Confident | 11 | 15.5 |
Some confidence | 22 | 31.0 |
Little confidence | 22 | 31.0 |
Not at all confident | 12 | 16.9 |
Confidence Counseling Patients on the Prevention of Xylazine Complications (n = 71) | ||
Extremely confident | 8 | 11.3 |
Confident | 19 | 26.8 |
Some confidence | 16 | 22.5 |
Little confidence | 17 | 23.9 |
Not at all confident | 11 | 15.5 |